Broncotron - 11026-2640-4 - (Dextromethorphan, Guaifenesin)

Alphabetical Index


Drug Information of Broncotron

Product NDC: 11026-2640
Proprietary Name: Broncotron
Non Proprietary Name: Dextromethorphan, Guaifenesin
Active Ingredient(s): 10; 100    mg/5mL; mg/5mL & nbsp;   Dextromethorphan, Guaifenesin
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Broncotron

Product NDC: 11026-2640
Labeler Name: Seyer Pharmatec, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 19980101

Package Information of Broncotron

Package NDC: 11026-2640-4
Package Description: 118 mL in 1 BOTTLE (11026-2640-4)

NDC Information of Broncotron

NDC Code 11026-2640-4
Proprietary Name Broncotron
Package Description 118 mL in 1 BOTTLE (11026-2640-4)
Product NDC 11026-2640
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Dextromethorphan, Guaifenesin
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 19980101
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Seyer Pharmatec, Inc.
Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Strength Number 10; 100
Strength Unit mg/5mL; mg/5mL
Pharmaceutical Classes

Complete Information of Broncotron


General Information